Ujjwal Rewati Raman, Slaughter Gymama
Center for Bioelectronics, Department of Electrical and Computer Engineering, Old Dominion University, Norfolk, Virginia, USA.
J Biomed Mater Res A. 2025 Apr;113(4):e37912. doi: 10.1002/jbm.a.37912.
Bacterial cellulose (BC) has emerged as a highly versatile and promising biomaterial in tissue engineering, with potential applications across skin, bone, cartilage, and vascular regeneration. Its exceptional properties like high mechanical strength, superior biocompatibility, excellent moisture retention, and inherent ability to support cell adhesion and proliferation, make BC particularly effective for wound healing and skin regeneration. These attributes accelerate tissue repair and foster new tissue formation, highlighting its value in skin-related applications. Additionally, BC's capacity to support osteogenic differentiation, combined with its mechanical robustness, positions it as a strong candidate for bone tissue engineering, facilitating regeneration and repair. Recent advancements have emphasized the development of BC-based hybrid scaffolds to enhance tissue-specific functionalities, including vascularization and cartilage regeneration. These innovations aim to address the complex requirements of various tissue engineering applications. However, challenges remain, particularly regarding the scalability of BC production, cost-effectiveness, and the long-term stability of BC-based scaffolds. Such barriers continue to limit its broader clinical adoption. This review critically examines the synthesis methods, intrinsic properties, and recent innovations in the design of BC-based scaffolds, offering insights into their potential to revolutionize regenerative medicine. Furthermore, it addresses the key challenges and limitations that must be overcome to enable the clinical integration of BC. By addressing these limitations, BC could play a transformative role in advancing tissue engineering and regenerative therapies, bridging the gap between laboratory research and clinical application.
细菌纤维素(BC)已成为组织工程中一种用途广泛且前景广阔的生物材料,在皮肤、骨骼、软骨和血管再生等方面具有潜在应用价值。它具有诸如高机械强度、卓越的生物相容性、出色的保湿性以及支持细胞黏附和增殖的内在能力等优异特性,使得BC在伤口愈合和皮肤再生方面特别有效。这些特性加速了组织修复并促进新组织形成,凸显了其在皮肤相关应用中的价值。此外,BC支持成骨分化的能力,结合其机械强度,使其成为骨组织工程的有力候选材料,有助于骨组织的再生和修复。最近的进展强调了基于BC的混合支架的开发,以增强组织特异性功能,包括血管生成和软骨再生。这些创新旨在满足各种组织工程应用的复杂需求。然而,挑战依然存在,特别是在BC生产的可扩展性、成本效益以及基于BC的支架的长期稳定性方面。这些障碍继续限制其在临床上的更广泛应用。本综述批判性地研究了基于BC的支架的合成方法、固有特性和近期创新,深入探讨了它们在革新再生医学方面的潜力。此外,它还探讨了实现BC临床整合必须克服的关键挑战和限制。通过克服这些限制,BC可以在推进组织工程和再生疗法方面发挥变革性作用,弥合实验室研究与临床应用之间的差距。